<DOC>
	<DOCNO>NCT01246310</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) one common reproductive disorder affect 5-10 % woman reproductive age . Beside impairment reproductive function ( oligomenorrhea/amenorrhea ) , also affect metabolism ( insulin resistance , type 2 diabetes mellitus cardiovascular risk ) psychology ( increased anxiety , depression eat disorder ) . Recently , several study show increased risk mood disorder woman PCOS , major depression bipolar disorder frequent diagnosis . Myo-inositol classified member vitamin B complex work second messenger system several neurotransmitter receptor ; furthermore , inositol , administrate pharmacological dos , cross blood-brain barrier . Studies 90 show inositol , alone combination antidepressant drug ( mainly serotonin reuptake inhibitor ) , able induce improvement Hamilton depression rating Scale . Recently , inositol propose treatment improve clinical , metabolic endocrinal status PCOS patient . Administration myo-inositol PCOs patient result several beneficial effect , decrease circulate insulin serum total testosterone well restored ovulation . In proposed study , investigator aim evaluate double blind randomize trial whether inositol alone beneficial effect mental health disorder associate PCOs . In particular , 60 woman reproductive age diagnose PCOs , accord Rotterdam 2003 criterion , recruit randomly assign inositol placebo group . Both group go ultrasonic evaluation ovary serum hormonal level ( FSH , LH , testosterone , estradiol insulin ) evaluate . Furthermore , help psychiatrics , patient interview order test presence mental health disorder use validated test : Hamilton Anxiety Scale ( HAM-A ) , Hamilton Rating Scale Depression ( HAM-D ) , Health Assessment Questionnaire ( HAQ ) , Short Form Mc Gill Pain Questionnaire ( SF-MPQ ) . Women assign inositol group receive 12g inositol day three different administration period 4weeks . At end treatment period patient interview psychiatrics go ultrasonic evaluation ovary hormonal level test</brief_summary>
	<brief_title>Myoinositol Treatment Ovarian Psychiatric Disorder Polycystic Ovary Syndrome ( PCOS ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>Women diagnose PCOS accord Rotterdam 2003 criterion BMI &gt; 30 Pharmacological treatment last 3 moth Use contraceptive pill</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>